arrow
H

Hiroshi Ogura

department of traumatology and acute critical medicine
H指数:69
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

National trends in inpatient rehabilitation utilization among patients with sepsis in Japan: a nationwide cohort study from 2010 to 2020 by the Japan Sepsis Alliance (JaSA) study group

2010年至2020年日本脓毒症患者住院康复利用的全国趋势:日本脓毒症联盟(JaSA)研究小组的全国队列研究

2026-08-290
OA
Association between empiric combination therapy using antipseudomonal agents and in-hospital mortality among patients with sepsis in intensive care units in Japan: A propensity score-matched analysis

日本重症监护病房中,使用抗假单胞菌药物的经验性联合治疗与脓毒症患者院内死亡率之间的关联:一项倾向性评分匹配分析

2026-01-020
PRE
Association between empiric multidrug-resistant coverage and in-hospital mortality in adults with sepsis who received empiric anti-MRSA therapy

成人脓毒症患者接受经验性抗MRSA治疗后,经验性多药耐药菌覆盖与院内死亡率之间的关联

2025-09-010
PRE
Utility of Sepsis-induced Coagulopathy among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study (Feb 27, 10.1055/a-2530-7553, 2025)

脓毒症诱导的凝血功能障碍在弥散性血管内凝血诊断标准中的效用:一项多中心回顾性验证研究(2025年2月27日,10.1055/a-2530-7553)

2025-04-250
PRE
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

2024年日本脓毒症与感染性休克管理临床实践指南

2025-03-140
OAAI
Utility of Sepsis-induced Coagulopathy among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study

脓毒症诱导的凝血病在弥散性血管内凝血诊断标准中的效用: 一项多中心回顾性验证研究

2025-02-270
PRE
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients
2024-09-170
OAAI
Atypical and non-classical CD45RBlo memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19
2024-08-091
OAAI
Proposal and Validation of a Clinically Relevant Modification of the Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Diagnostic Criteria for Sepsis
2024-05-104
OAAI